期刊
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
卷 28, 期 7, 页码 2479-2486出版社
SPRINGER
DOI: 10.1007/s11274-012-1055-9
关键词
Fibrinolytic enzyme; Purification; Streptomyces; Thrombolytic therapy
资金
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
- National Natural Science Foundation of China [31000005, 31170605]
- Project of Outstanding Scientific and Technological Innovation Team for Higher Education Institutions in Jiangsu Province
- University-Industry Cooperation Program of Jiangsu Province [BY2009116]
A fibrinolytic enzyme (SFE1) from Streptomyces sp. XZNUM 00004 was purified to electrophoretic homogeneity with the methods including ammonium sulfate precipitation, polyacrylamide gel, DEAE-Sepharose Fast Flow anion exchange and gel-filtration chromatography. The molecular weight of SFE1 was estimated to be 20 kDa by SDS-PAGE, fibrin zymography, and gel filtration chromatography. The isoelectric point was 4.9. Km and Vmax values were 0.96 mg/ml and 181.8 unit/ml, respectively. It was very stable at pH 5.0-8.0 and below 65 degrees C. The optimum pH for enzyme activity was 7.8. The optimum temperature was 35 degrees C. The fibrinolytic activity of SFE1 was enhanced by Na+, K+, Mn2+, Mg2+, Zn2+ and Co2+. Conversely, Cu2+ showed strong inhibition. Furthermore, the fibrinolytic activity was strongly inhibited by PMSF, and partly inhibited by EDTA and EGTA. SFE1 rapidly hydrolyzed the Aa-chain of fibrinogen, followed by the Bb-chain and finally the c-chain. The first 15 amino acids of the N-terminal sequence were API-TLSQGHVDVVDI. Additionally, SFE1 directly digested fibrin and not by plasminogen activators in vitro. SFE1 can be further developed as a potential candidate for thrombolytic therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据